Pharmalys

Partner Pharmalys

Marieme Ba

Partner DO-HEALTH – Clinical Monitoring

Marieme Ba has a Master of Immunology, Bachelor of Sciences, and business school degree. She has 17 years of experience in the pharmaceutical industry with 14 years spent in small and large Contract Research Organisations and mid size pharmaceutical companies. She started as a monitor, and then was nominated Clinical Research Manager. She is the founder of Pharmalys Ltd that was created 4 years ago.

E-Mail: marieme.ba@pharmalys.com


Anna Polak

Partner DO-HEALTH – Clinical Monitoring

Anna Polak has a Master’s degree in Pharmacy is working in clinical research for over 6 years. Her therapeutic experience includes clinical trials in neurology, oncology and infectious diseases and in clinical trial phases II-IV. She started her career as a Clinical Research Associate and was promoted to a Clinical Project Manager at Pharmalys. Anna is a member of a Special Interest Group at the Institute of Clinical Research.

E-Mail: anna.polak@pharmalys.com

Pharmalys is a UK-based Contract Research Organisation (CRO) with extensive expertise across a wide range of therapeutic areas. Pharmalys provides innovative solutions throughout Europe and covers all clinical trial phases in a proactive and cost-conscious way. They manage local and international projects from the trial feasibility assessment right through to study reporting for small or large projects.

Website: www.pharmalys.com


As the DO-HEALTH independent clinical monitoring partner,
Pharmalys will ensure that at all recruitment sites, SOPs are followed and all data collection and adverse event documentation is according to Good Clinical Practice. All sites will be thoroughly trained prior to the enrolment of their first participant. After the training, regular site monitor visits will occur for all 4 clinical visits followed by a close-out visit at the end of the trial. Pharmalys supports the recruitment centers in the application for each country’s ethical and competent authority authorization for the clinical trial. Pharmalys will write an ongoing report of Adverse Events to the data safety and monitoring board and will review at each site visit, the ongoing collection and maintenance of study master files.